|
US2616927A
(en)
|
1950-05-12 |
1952-11-04 |
Minnesota Mining & Mfg |
Fluorocarbon tertiary amines
|
|
US4452818A
(en)
|
1982-03-19 |
1984-06-05 |
Haidt Sterling J |
Extraocular method of treating the eye with liquid perfluorocarbons
|
|
US4649047A
(en)
|
1985-03-19 |
1987-03-10 |
University Of Georgia Research Foundation, Inc. |
Ophthalmic treatment by topical administration of cyclosporin
|
|
US5077036A
(en)
|
1986-01-14 |
1991-12-31 |
Alliance Pharmaceutical Corp. |
Biocompatible stable fluorocarbon emulsions for contrast enhancement and oxygen transport comprising 40-125% wt./volume fluorocarbon combined with a phospholipid
|
|
FR2638089A1
(fr)
|
1988-10-26 |
1990-04-27 |
Sandoz Sa |
Nouvelles compositions ophtalmiques a base d'une cyclosporine
|
|
US6458376B1
(en)
|
1990-09-27 |
2002-10-01 |
Allergan, Inc. |
Nonaqueous fluorinated drug delivery suspensions
|
|
US5518731A
(en)
|
1990-09-27 |
1996-05-21 |
Allergan, Inc. |
Nonaqueous fluorinated drug delivery vehicle suspensions
|
|
FR2679150A1
(fr)
|
1991-07-17 |
1993-01-22 |
Atta |
Preparations comprenant un fluorocarbure ou compose hautement fluore et un compose organique lipophile-fluorophile, et leurs utilisations.
|
|
US5336175A
(en)
|
1992-10-29 |
1994-08-09 |
Mames Robert N |
Method for the treatment of retinal detachments
|
|
DE4405627A1
(de)
|
1994-02-22 |
1995-08-24 |
Hoechst Ag |
Fluorkohlenwasserstoffe enthaltende Ölemulsionen
|
|
FR2720943B1
(fr)
|
1994-06-09 |
1996-08-23 |
Applic Transferts Technolo |
Emulsions inverses stables à forte concentration en composé(s) fluoré(s) et leur utilisation pour l'administration pulmonaire de médicaments et pour la fabrication d'émulsions multiples.
|
|
US5874481A
(en)
|
1995-06-07 |
1999-02-23 |
Alliance Pharmaceutical Corp. |
Fluorochemical solutions for the delivery of lipophilic pharmaceutical agents
|
|
US5667809A
(en)
|
1995-06-07 |
1997-09-16 |
Alliance Pharmaceutical Corp. |
Continuous fluorochemical microdispersions for the delivery of lipophilic pharmaceutical agents
|
|
DE19536504C2
(de)
|
1995-09-29 |
1999-09-23 |
H Meinert |
Verwendung fluorierter Alkane
|
|
US5874469A
(en)
|
1996-01-05 |
1999-02-23 |
Alcon Laboratories, Inc. |
Fluoroalkyl hydrocarbons for administering water insoluble or unstable drugs
|
|
US5980936A
(en)
|
1997-08-07 |
1999-11-09 |
Alliance Pharmaceutical Corp. |
Multiple emulsions comprising a hydrophobic continuous phase
|
|
US6335335B2
(en)
|
1997-11-05 |
2002-01-01 |
Senju Pharmaceutical Co., Ltd. |
Prolonged-action eye drop
|
|
US5981607A
(en)
|
1998-01-20 |
1999-11-09 |
Allergan |
Emulsion eye drop for alleviation of dry eye related symptoms in dry eye patients and/or contact lens wearers
|
|
DE19861012A1
(de)
|
1998-03-18 |
1999-09-30 |
Pharm Pur Gmbh |
Behandlungsmittel für die Ophthalmologie
|
|
DE69912441T2
(de)
|
1998-08-19 |
2004-08-19 |
Skyepharma Canada Inc., Verdun |
Injizierbare wässerige propofoldispersionen
|
|
US6140374A
(en)
|
1998-10-23 |
2000-10-31 |
Abbott Laboratories |
Propofol composition
|
|
US7258869B1
(en)
|
1999-02-08 |
2007-08-21 |
Alza Corporation |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
|
|
US6239113B1
(en)
|
1999-03-31 |
2001-05-29 |
Insite Vision, Incorporated |
Topical treatment or prevention of ocular infections
|
|
DE19926890C1
(de)
|
1999-06-12 |
2000-07-27 |
Pharm Pur Gmbh |
Verwendung eines hochfluorierten oligomeren Alkans in der Ophthalmologie
|
|
DE19938668B4
(de)
|
1999-08-14 |
2006-01-26 |
Bausch & Lomb Inc. |
Tränenersatzmittel
|
|
US20030018044A1
(en)
|
2000-02-18 |
2003-01-23 |
Peyman Gholam A. |
Treatment of ocular disease
|
|
TWI298257B
(en)
|
2001-05-31 |
2008-07-01 |
Allergan Inc |
Hypotensive lipid and timolol compositions and methods of using same
|
|
US7074827B2
(en)
|
2002-10-24 |
2006-07-11 |
Sucampo Ag (Usa) Inc. |
Method for treating ocular hypertension and glaucoma
|
|
US7087237B2
(en)
*
|
2003-09-19 |
2006-08-08 |
Advanced Ocular Systems Limited |
Ocular solutions
|
|
US20050079210A1
(en)
|
2003-10-09 |
2005-04-14 |
Gupta Shyam K. |
Liposomal delivery system for topical pharmaceutical, cosmeceutical, and cosmetic ingredients
|
|
JP2007511616A
(ja)
|
2003-11-19 |
2007-05-10 |
バーンズ−ジューイッシュ ホスピタル |
増強された薬物送達
|
|
WO2007008666A2
(en)
|
2005-07-08 |
2007-01-18 |
Ocularis Pharma, Inc. |
Compositions and methods for improving vision using adherent thin films
|
|
DE102005055811A1
(de)
|
2005-11-23 |
2007-05-31 |
Novaliq Gmbh |
Verwendung einer Zusammensetzung zur Konservierung von Organen und Gliedmaßen
|
|
EP2070518A2
(en)
|
2006-07-25 |
2009-06-17 |
Osmotica Corp. |
Ophthalmic solutions
|
|
EP2099408B1
(en)
|
2006-11-28 |
2016-10-05 |
Wisconsin Alumni Research Foundation |
Fluoropolymer-based emulsions for the intravenous delivery of fluorinated volatile anesthetics
|
|
ITMI20070890A1
(it)
|
2007-05-04 |
2008-11-05 |
Sifi Spa |
Composizioni oftalmiche per il trattamento della ipertensione oculare e del glaucoma
|
|
US8492334B2
(en)
|
2007-06-21 |
2013-07-23 |
Yale University |
Sustained intraocular delivery of drugs from biodegradable polymeric microparticles
|
|
FR2918891B1
(fr)
|
2007-07-20 |
2009-09-25 |
Thea Sa Lab |
Solution ophtalmique a base de prostaglandines sans conservateur
|
|
DE102007055046A1
(de)
|
2007-11-19 |
2009-05-28 |
Fluoron Gmbh |
Infusionslösung
|
|
EP2242504B1
(en)
|
2008-01-09 |
2021-07-14 |
The Schepens Eye Research Institute, Inc. |
Therapeutic compositions for treatment of ocular inflammatory disorders
|
|
ES2377152T3
(es)
|
2008-04-18 |
2012-03-22 |
Novaliq Gmbh |
Uso inhalativo e instilativo de alcanos semifluorados como vehículos de principios activos en la región intrapulmonar
|
|
US8669241B2
(en)
|
2008-12-02 |
2014-03-11 |
Rohto Pharmaceutical Co., Ltd. |
Ophthalmic composition
|
|
US8501800B2
(en)
|
2009-03-05 |
2013-08-06 |
Insite Vision Incorporated |
Controlled-release ophthalmic vehicles
|
|
IT1393419B1
(it)
|
2009-03-19 |
2012-04-20 |
Medivis S R L |
Composizioni oftalmiche a base di acidi grassi polinsaturi omega-3 e omega-6.
|
|
WO2010127301A1
(en)
|
2009-05-01 |
2010-11-04 |
Allergan, Inc. |
Method of treating allergic conjunctivitis with cyclosporin compositions
|
|
EP2332525A1
(en)
|
2009-11-23 |
2011-06-15 |
Novaliq GmbH |
Pharmaceutical composition comprising propofol
|
|
EP2335735A1
(en)
|
2009-12-14 |
2011-06-22 |
Novaliq GmbH |
Pharmaceutical composition for treatment of dry eye syndrome
|
|
US20110223208A1
(en)
|
2010-03-09 |
2011-09-15 |
Beth Hill |
Non-Aqueous High Concentration Reduced Viscosity Suspension Formulations
|
|
PL2547323T3
(pl)
|
2010-03-17 |
2016-07-29 |
Novaliq Gmbh |
Kompozycja farmaceutyczna do leczenia podwyższonego ciśnienia wewnątrzgałkowego
|
|
DE102010022567A1
(de)
|
2010-06-02 |
2011-12-08 |
Fluoron Gmbh |
Zubereitung
|
|
EP2444063A1
(en)
|
2010-10-20 |
2012-04-25 |
Novaliq GmbH |
Liquid pharmaceutical compositions for the delivery of active ingredients
|
|
EP2462921A1
(en)
|
2010-11-11 |
2012-06-13 |
Novaliq GmbH |
Liquid pharmaceutical compositions for the treatment of a posterior eye disease
|
|
ES2711760T3
(es)
|
2011-01-04 |
2019-05-07 |
Novaliq Gmbh |
Emulsiones de aceite/agua que comprenden alcanos semifluorados
|
|
DK2714010T3
(en)
|
2011-05-25 |
2017-06-12 |
Novaliq Gmbh |
TOPICAL PHARMACEUTICAL COMPOSITION BASED ON SEMIFLUORED ALKANES
|
|
JP6023181B2
(ja)
|
2011-05-25 |
2016-11-09 |
ノバリック ゲーエムベーハー |
爪に投与するための医薬組成物
|
|
KR101989648B1
(ko)
|
2012-01-23 |
2019-06-14 |
노바리크 게엠베하 |
부분불소화 알칸에 기초한 안정화된 단백질 조성물
|
|
US9549966B2
(en)
|
2012-02-21 |
2017-01-24 |
Massachusetts Eye & Ear Infirmary |
Inflammatory eye disorders
|
|
US9878000B2
(en)
|
2012-06-20 |
2018-01-30 |
University Of Waterloo |
Mucoadhesive nanoparticle composition comprising immunosuppresant and methods of use thereof
|
|
HK1210417A1
(en)
|
2012-07-09 |
2016-04-22 |
华柏恩视觉研究中心 |
Compositions, methods and/or devices for prevention and/or treatment of dry eye disorders
|
|
CN113679699B
(zh)
|
2012-09-12 |
2022-10-28 |
诺瓦利克有限责任公司 |
包含半氟化烷烃的混合物的组合物
|
|
AU2013314303B2
(en)
|
2012-09-12 |
2018-01-18 |
Novaliq Gmbh |
Semifluorinated alkane compositions
|
|
DK2708228T3
(en)
|
2012-09-12 |
2018-08-20 |
Novaliq Gmbh |
COMPOSITION FOR EYE RINSE
|
|
EP2730291A1
(en)
|
2012-11-09 |
2014-05-14 |
Fluoron Gmbh |
Internal Tamponade Composition
|
|
TW201427989A
(zh)
|
2012-12-18 |
2014-07-16 |
Novartis Ag |
長效性蛋白質之組合物及方法
|
|
WO2014152661A1
(en)
|
2013-03-14 |
2014-09-25 |
Panoptica, Inc. |
Ocular formulations for drug-delivery to the posterior segment of the eye
|
|
EP2783703A1
(en)
|
2013-03-25 |
2014-10-01 |
B. Braun Melsungen AG |
Semifluorocarbon compound containing contrast agent
|
|
PT3024484T
(pt)
|
2013-07-23 |
2018-10-24 |
Novaliq Gmbh |
Composições de anticorpo estabilizadas
|
|
AU2014332488B2
(en)
|
2013-10-09 |
2017-03-09 |
Johnson Living Trust Dated October 26, 2001, Leonidas A. Johnson, Trustee |
Methods and compositions for treating and preventing signs or symptoms of eye disease
|
|
EP3209331B1
(en)
|
2014-10-20 |
2023-07-12 |
Sentiss Pharma Private Limited |
Ophthalmic solution
|
|
WO2016082644A1
(en)
|
2014-11-26 |
2016-06-02 |
The University Of Hong Kong |
A semifluorinated alkane based cleaner for removing emulsified droplets in the eye to reduce the complications associated with the emulsification of silicone oil
|
|
MA41299A
(fr)
|
2014-12-30 |
2017-11-07 |
Axim Biotechnologies Inc |
Solutions ophtalmiques pour le traitement du glaucome et de la conjonctivite
|
|
CN110403923B
(zh)
|
2015-09-30 |
2021-09-21 |
诺瓦利克有限责任公司 |
半氟化化合物和其组合物
|
|
US11154513B2
(en)
|
2015-09-30 |
2021-10-26 |
Novaliq Gmbh |
Semifluorinated compounds
|
|
EP3362096B1
(en)
|
2015-10-14 |
2023-12-13 |
Paul Gavaris |
Ophthalmic treatment composition and vehicle for delivery of pharmaceutical substances or therapeutic agents
|
|
EP3463344A4
(en)
|
2016-06-01 |
2020-02-12 |
Harold Richard Hellstrom |
TREATMENT OF DRY EYE WITH PARASYMPATHIC AND ANTISYMPATHIC AGENTS
|
|
PT3442480T
(pt)
|
2016-06-23 |
2019-12-23 |
Novaliq Gmbh |
Método de administração tópica
|
|
WO2018033854A1
(en)
|
2016-08-15 |
2018-02-22 |
Santen Pharmaceutical Co., Ltd. |
Ophthalmic composition and a method for treating ocular hypertension and glaucoma
|
|
CA3036297C
(en)
|
2016-09-22 |
2023-09-05 |
Novaliq Gmbh |
Pharmaceutical compositions for use in the therapy of blepharitis
|
|
WO2018055101A1
(en)
|
2016-09-23 |
2018-03-29 |
Novaliq Gmbh |
Ophthalmic compositions comprising ciclosporin
|
|
AU2017333420A1
(en)
|
2016-09-28 |
2019-04-04 |
Novaliq Gmbh |
Compositions comprising a cannabinoid receptor binding ligand
|
|
BR112019012568A2
(pt)
|
2016-12-22 |
2019-11-26 |
Novaliq Gmbh |
composições compreendendo tacrolimus para o tratamento de doenças intraoculares inflamatórias
|
|
EP4374851B1
(en)
*
|
2016-12-23 |
2026-04-15 |
Novaliq GmbH |
Ophthalmic composition for treatment of dry eye disease
|
|
CA3058097C
(en)
|
2017-04-21 |
2024-01-02 |
Novaliq Gmbh |
Iodine compositions
|
|
WO2018206386A1
(en)
|
2017-05-06 |
2018-11-15 |
Novaliq Gmbh |
Drop dispenser
|
|
US11278503B2
(en)
|
2017-05-12 |
2022-03-22 |
Novaliq Gmbh |
Pharmaceutical compositions comprising semifluorinated alkanes for the treatment of contact lense-related conditions
|
|
MX2020003534A
(es)
|
2017-09-27 |
2020-07-29 |
Novaliq Gmbh |
Composiciones oftalmicas que comprenden latanoprost para usarse en el tratamiento de las enfermedades oculares.
|
|
WO2019068763A1
(en)
|
2017-10-04 |
2019-04-11 |
Novaliq Gmbh |
OPHTHALMIC COMPOSITIONS COMPRISING F6H8
|
|
KR20200128407A
(ko)
|
2018-03-02 |
2020-11-12 |
노바리크 게엠베하 |
네비볼롤을 포함하는 약제학적 조성물
|
|
SG11202007860XA
(en)
|
2018-03-28 |
2020-09-29 |
Novaliq Gmbh |
Pharmaceutical composition comprising timolol
|
|
CN112153970A
(zh)
|
2018-04-27 |
2020-12-29 |
诺瓦利克有限责任公司 |
用于治疗青光眼的包含他氟前列素的眼用组合物
|
|
WO2020058504A1
(en)
|
2018-09-22 |
2020-03-26 |
Novaliq Gmbh |
Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness
|
|
EP3856124A1
(en)
|
2018-09-27 |
2021-08-04 |
Novaliq GmbH |
Lipid barrier repair
|
|
SG11202102820VA
(en)
|
2018-10-12 |
2021-04-29 |
Novaliq Gmbh |
Ophthalmic composition for treatment of dry eye disease
|
|
ES2989413T3
(es)
|
2018-11-27 |
2024-11-26 |
Novaliq Gmbh |
Composiciones de alcanos semifluorados que comprenden ésteres etílicos de ácidos grasos omega-3
|
|
EP3923907B1
(en)
|
2019-02-13 |
2024-09-25 |
Novaliq GmbH |
Compositions and methods for the treatment of ocular neovascularization
|
|
WO2020239646A1
(en)
|
2019-05-24 |
2020-12-03 |
Novaliq Gmbh |
Ophthalmic composition for the treatment of ocular allergy
|
|
JP2022543402A
(ja)
|
2019-08-09 |
2022-10-12 |
ノバリック ゲーエムベーハー |
プロスタグランジンアナログを含む局所組成物
|
|
KR20220058577A
(ko)
|
2019-09-06 |
2022-05-09 |
노바리크 게엠베하 |
포도막염 치료를 위한 안과용 조성물
|